Supply Issues Becton Dickinson UK Ltd Woking Biopsy Needles FYU3207, FYU3254 and FRZ3041 (ICN 3417)

• The supply issue with biopsy needle products from Becton Dickinson is now resolved.
• FYU3207, FYU3254 and FRZ3041 are now available to order through our online catalogue.
• This ICN is now closed.

Change:

• The supplier Becton Dickinson has informed us of a supply issue with its biopsy needle products.
• There are three product codes affected:
  • FYU3207 – Biopsy Needles (IR) Encor insert mammotest – 10g
  • FYU3254 – Biopsy Needles (IR) Insert lorad 10g
  • FRZ3041 – Biopsy Needles (IR) Vacuum assisted senomark ultra marker 10-gauge ribbon.
• The supply issue is due to supplier manufacturing issues.

 Impact:          

• The affected products are currently available whilst stock lasts, once the stock is depleted the product codes will be unavailable to order.
• A potential indirect alternative is available to order through our online catalogue for the below product:
  • FRZ3041- Biopsy Needles (IR) Vacuum assisted senomark ultra marker 10 gauge coil.
• Unfortunately, there are no alternatives for two of the affected product codes. Customers are advised to view the online catalogue for products they deem suitable:
  • FYU3207 and FYU3254.
• See our Downloads ▼ section to access the product listing for further information on the affected product codes and potential alternative.
• The supply issue is anticipated to be resolved by 30 August 2026.

Next Steps:               

• Customers are advised to log into our website to view the product listing for further information on the affected product codes and potential alternative.
• The continuing supply issue is being monitored in conjunction with the supplier, and we will continue to review the stock situation to minimise further disruption and update this ICN with the latest information as it becomes available.
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.

Please note that due to the clinical nature of these alternative products, we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.